Increasing access to biosimilar medicines.

 H-0924.1

HOUSE BILL 1725

State of Washington

69th Legislature

2025 Regular Session

By Representatives Thai, Shavers, Parshley, Duerr, and Macri

Read first time 01/30/25. Referred to Committee on Health Care & Wellness.

AN ACT Relating to reducing prescription drug costs by eliminating barriers impeding access to biosimilar medicines; amending RCW 48.43.420 , 41.05.410 , 69.41.120 , and 69.41.125 ; and creating a new section.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:

NEW SECTION. Sec. 1. (1) The legislature finds that increasing access to biosimilar medicines has the potential to significantly reduce prescription drug costs. Biosimilar medicines are approved according to the same food and drug administration standards of pharmaceutical quality, safety, and efficacy as their reference medicines.

(2) The legislature intends to eliminate barriers impeding access to biosimilar medicines and the savings they can provide.